Mar 3, 2026 04:02PM
Feb 5, 2026 09:26AM
Dec 16, 2025 12:18PM
Dec 16, 2025 07:20AM
Dec 15, 2025 07:00AM
Dec 15, 2025 07:00AM
Nov 17, 2025 07:08AM Immunome Inc. (IMNM) PT Raised to $33 at Stephens
Aug 6, 2025 04:05PM
Feb 11, 2025 08:30AM
Jan 13, 2025 08:00AM
Oct 29, 2024 08:00AM
Oct 18, 2024 08:00AM
Jul 25, 2024 08:00AM
Mar 26, 2024 08:00AM Immunome Completes Acquisition of AL102, a Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala
Feb 20, 2024 08:00AM
Feb 6, 2024 08:00AM
Feb 6, 2024 08:00AM
Nov 9, 2023 08:00AM
Oct 3, 2023 08:05AM
Oct 3, 2023 08:00AM
Jun 29, 2023 09:01AM Immunome Inc. (IMNM) and Morphimmune Announce Definitive Merger Agreement and Simultaneous Private Placement Investment of $125 Million
Jun 29, 2023 09:00AM
May 23, 2023 04:07PM
May 23, 2023 04:05PM
May 5, 2023 08:00AM
Mar 16, 2023 08:00AM
Mar 9, 2023 08:45AM
Feb 8, 2023 08:00AM Immunome Announces Formation of Antibody-Drug Conjugate and T Cell Redirection Advisory Board
Jan 6, 2023 08:02AM
Jan 6, 2023 08:00AM
Jan 6, 2023 08:00AM
Nov 14, 2022 08:00AM
Nov 9, 2022 12:04PM
Nov 9, 2022 12:00PM
Nov 7, 2022 08:17AM Immunome (IMNM) Presents Preclinical Data on Novel Anti-EPN1 Antibody IMM20059
Nov 7, 2022 08:15AM
Aug 23, 2022 09:00AM
Aug 5, 2022 08:00AM
Jul 6, 2022 08:02AM
Jul 6, 2022 08:00AM
Jun 9, 2022 08:04AM
Jun 9, 2022 08:00AM Immunome Announces Initiation of Phase 1b Study of IMM-BCP-01 for the Treatment of COVID-19
May 23, 2022 08:00AM
May 19, 2022 08:01AM
May 19, 2022 08:00AM
May 12, 2022 08:00AM
Mar 28, 2022 08:00AM
Mar 11, 2022 08:00AM
Mar 11, 2022 08:00AM FDA Lifts Clinical Hold on Immunome’s IMM-BCP-01 IND Application for the Treatment of COVID-19
Feb 8, 2022 08:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All